Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-446-2 | CAS number: 125768-93-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral and dermal LD0 of 1,1-dimethylpropyl 1-methoxycyclohexyl peroxide are higher than 2000 mg/kg bw.
Oral route
The potential for oral toxicity of 1,1-dimethylpropyl 1-methoxycyclohexyl peroxide (Luperox XPS-TP) was evaluated using the Acute Toxic Class Determination following the OECD Guidelines no. 423 (Cerven, 2005a). Three healthy male and three healthy female Wistar albino rats were dosed orally with Luperox XPS-TP at 2000 mg/kg. The rats were observed 0.5, 1, 2, 3 and 4 hours postdose and once daily for 14 days for mortality, toxicity and pharmacological effects. Body weights were recorded immediately pretest, weekly and at termination. All animals were examined for gross pathology. Abnormal tissues were preserved in 10% neutral buffered formalin for possible future histological examination. All three male and three female animais survived the 2000 mg/kg oral dose. Instances of localized alopecia were the only abnormal physical signs noted during the observation period. Body weight changes were normal 5/6 animals. One female lost a slight amount of body weight between day 7 and day 14. Necropsy results revealed localized alopecia in two animals and darker than normal kidneys in 5/6 animals. One animal appeared normal during necropsy. The LD0 is > 2000 mg/kg.
Dermal route
The potential for toxicity of 1,1-dimethylpropyl 1-methoxycyclohexyl peroxide (Luperox XPS-TP) when applied dermally was evaluated following the OECD Guideline no. 402 (Gilotti, 2005b). Five healthy male and five healthy female Wistar Albino rats were dosed dermally with Luperox XPS-TP at 2000 mg/kg of body weight. The test article was kept in contact with the skin for 24 hours. Dermal responses were recorded at 24 hours postdose and on days 7 and 14. Animals were observed for toxicity and pharmacological effects at 1, 2 and 4 hours postdose and once daily for 14 days. All animals were observed twice a day for mortality. Body weights were recorded pretest, weekly and at termination. All animals were examined for gross pathology. Abnormal tissues were preserved in 10% neutral buffered formalin for possible future histological examination. All ten animals survived the 2000 mg/kg dermal application. Instances of chromorhinorrhea were noted during exposure and instances of alopecia on the front limbs were noted during the study. Dermal effects were absent during the study. Body weight changes were normal in 8/10 animals. One female lost weight during the first week, but gained normally during the second week. Another female lost weight during the second week. Necropsy results revealed abnormalities of the kidneys in 7/10 animals and alopecia was noted in 2 females. The dermal LD0 is higher than 2000 mg/kg of body weight.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ace Animais, Boyertown, PA
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 366 - 397 grams for males and 241 - 273 grams for females
- Fasting period before study: yes
- Housing: in suspended wire mesh cages; 5/sex/cage prier to dosing and 3/sex/cage following dosing
- Diet: Fresh PMI Rat Chow, ad libitum
- Water: ad libitum
- Acclimation period:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2.08 ml/kg
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Animals were observed at 1/2, 1, 2, 3 & 4 hours post-dose and once daily thereafter for 14 consecutive days for mortality, toxicity & pharmacological effects.
Body Weights were recorded immediately pretest, weekly and at death or study termination in the survivors.
- Necropsy of survivors performed: yes - Key result
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- other: no mortality
- Mortality:
- Ali three male and three female animais survived the 2000 mg/kg oral dose.
- Clinical signs:
- Instances of localized alopecia were the only abnormal physical signs noted during the observation period.
- Body weight:
- Body weight changes were normal 516 animals. One female lost a slight amount of body weight
between day 7 and day 14. - Gross pathology:
- Necropsy results revealed localized alopecia in two. animais and darker than normal kidneys in 5/6
animais. One animal appeared normal during necropsy. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LD0 is > 2000 mg/kg.
- Executive summary:
The potential for oral toxicity of Luperox XPS-TP was evaluated using the Acute Toxic Class Determinationfollowing the OECD Guidelines no. 423. Three healthy male and three healthy female Wistar albino rats were dosed orally with Luperox XPS-TP at 2000 mg/kg. The rats were observed 0.5, 1, 2, 3 and 4 hours postdose and once daily for 14 days for mortality, toxicity and pharmacological effects. Body weights were recorded immediately pretest, weekly and at termination. All animals were examined for gross pathology. Abnormal tissues were preserved in 10% neutral buffered formalin for possible future histological examination. All three male and three female animais survived the 2000 mg/kg oral dose. Instances of localized alopecia were the only abnormal physical signs noted during the observation period. Body weight changes were normal 5/6 animals. One female lost a slight amount of body weight between day 7 and day 14. Necropsy results revealed localized alopecia in two animals and darker than normal kidneys in 5/6 animals. One animal appeared normal during necropsy. The LD0 is > 2000 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ace Animais, Boyertown, PA
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 229 - 280 g for males and 199 - 280 g for females.
- Fasting period before study: yes
- Housing: in suspended wire mesh cages; 1/cage
- Diet: Fresh PMI Rat Chow, ad libitum
- Water: ad libitum
- Acclimation period:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorsal area of the trunk
- % coverage: 4 x 6 cm
- Type of wrap if used:The torso was wrapped with plastic in a semi-occlusive manner and was secured with non-irritating tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done):Residual test article was removed by gently washing with distilled water.
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2.08 ml/kg - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Animals were observed at 1/2, 1, 2, 3 & 4 hours post-dose and once daily thereafter for 14 consecutive days for mortality, toxicity & pharmacological effects.
Body Weights were recorded immediately pretest, weekly and at death or study termination in the survivors.
The test sites were scored for dermal irritation at 24 hours postdose and on days 7 and 14.
- Necropsy of survivors performed: yes - Key result
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortality
- Mortality:
- Ali ten animais survived the 2000 mg/kg dermal application.
- Clinical signs:
- Instances of chromorhinorrhea were noted during exposure and instances of alopecia on the front limbs were noted during the study.
- Body weight:
- Body weight changes were normal in 8/1 O animais. One female lost weight du ring the first week, but gained normally during the second week. Another female lost weight during the second week.
- Gross pathology:
- Necropsy results revealed abnormalities of the kidneys in 7/10 animais and alopecia was noted in 2 females.
- Other findings:
- Dermal effects were absent during the study.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The dermal LD0 of Luperox XPS-TP is >= 2000 mg/kg of body weight.
- Executive summary:
The potential for toxicity of Luperox XPS-TP when applied dermally was evaluated following the OECD Guidelineno. 402. Five healthy male and five healthy female Wistar Albino rats were dosed dermally with Luperox XPS-TP at 2000 mg/kg of body weight. The test article was kept in contact with the skin for 24 hours. Dermal responses were recorded at 24 hours postdose and on days 7 and 14. Animals were observed for toxicity and pharmacological effects at 1, 2 and 4 hours postdose and once daily for 14 days. All animals were observed twice a day for mortality. Body weights were recorded pretest, weekly and at termination. All animals were examined for gross pathology. Abnormal tissues were preserved in 10% neutral buffered formalin for possible future histological examination. All ten animals survived the 2000 mg/kg dermal application. Instances of chromorhinorrhea were noted during exposure and instances of alopecia on the front limbs were noted during the study. Dermal effects were absent during the study. Body weight changes were normal in 8/10 animals. One female lost weight during the first week, but gained normally during the second week. Another female lost weight during the second week. Necropsy results revealed abnormalities of the kidneys in 7/10 animals and alopecia was noted in 2 females. The dermal LD0 of Luperox XPS-TP is higher than 2000 mg/kg of body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Additional information
Justification for classification or non-classification
No classification is warranted according to CLP/GHS criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.